Genome-wide discovery of hidden genes mediating known drug-disease association
暂无分享,去创建一个
[1] M. DePamphilis,et al. HUMAN DISEASE , 1957, The Ulster Medical Journal.
[2] J. Flier,et al. Obesity and insulin resistance. , 2000, The Journal of clinical investigation.
[3] G. Fischbach,et al. Neuregulin and ErbB receptor signaling pathways in the nervous system , 2001, Current Opinion in Neurobiology.
[4] M. Salmivirta,et al. Changes in matrix proteoglycans induced by insulin and fatty acids in hepatic cells may contribute to dyslipidemia of insulin resistance. , 2001, Diabetes.
[5] Leena Peltonen,et al. GRACILE syndrome, a lethal metabolic disorder with iron overload, is caused by a point mutation in BCS1L. , 2002, American journal of human genetics.
[6] T. Ashburn,et al. Drug repositioning: identifying and developing new uses for existing drugs , 2004, Nature Reviews Drug Discovery.
[7] Shailesh V. Date,et al. A Probabilistic Functional Network of Yeast Genes , 2004, Science.
[8] A. Barabasi,et al. Network biology: understanding the cell's functional organization , 2004, Nature Reviews Genetics.
[9] E. Arner,et al. Adipocyte lipases and defect of lipolysis in human obesity. , 2005, Diabetes.
[10] B. Sarkadi,et al. Tyrosine kinase inhibitor resistance in cancer: role of ABC multidrug transporters. , 2005, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.
[11] David Bradley,et al. Why big pharma needs to learn the three 'R's , 2005, Nature Reviews Drug Discovery.
[12] S. Khan,et al. Enhancing hepatic glycolysis reduces obesity: differential effects on lipogenesis depend on site of glycolytic modulation. , 2005, Cell metabolism.
[13] Paul A Clemons,et al. The Connectivity Map: Using Gene-Expression Signatures to Connect Small Molecules, Genes, and Disease , 2006, Science.
[14] G. V. Paolini,et al. Global mapping of pharmacological space , 2006, Nature Biotechnology.
[15] H. Ghofrani,et al. Sildenafil: from angina to erectile dysfunction to pulmonary hypertension and beyond , 2006, Nature Reviews Drug Discovery.
[16] A. Barabasi,et al. The human disease network , 2007, Proceedings of the National Academy of Sciences.
[17] A. Barabasi,et al. Drug—target network , 2007, Nature Biotechnology.
[18] Oliver Gautschi,et al. Cyclin D1 in non-small cell lung cancer: a key driver of malignant transformation. , 2007, Lung cancer.
[19] A. Fraser,et al. A single gene network accurately predicts phenotypic effects of gene perturbation in Caenorhabditis elegans , 2008, Nature Genetics.
[20] M. Tang,et al. SPARC in cancer biology: its role in cancer progression and potential for therapy. , 2008, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.
[21] Michael Q. Zhang,et al. Network-based global inference of human disease genes , 2008, Molecular systems biology.
[22] A. Hopkins. Network pharmacology: the next paradigm in drug discovery. , 2008, Nature chemical biology.
[23] M. Mattson,et al. Notch: from neural development to neurological disorders , 2008, Journal of neurochemistry.
[24] Sven Bergmann,et al. A modular approach for integrative analysis of large-scale gene-expression and drug-response data , 2008, Nature Biotechnology.
[25] J. Gómez. Growth hormone and insulin-like growth factor-I as an endocrine axis in Alzheimer's disease. , 2008, Endocrine, metabolic & immune disorders drug targets.
[26] P. Bork,et al. Drug Target Identification Using Side-Effect Similarity , 2008, Science.
[27] B. Viollet,et al. Targeting the AMPK pathway for the treatment of Type 2 diabetes. , 2009, Frontiers in bioscience.
[28] S. Yan,et al. RAGE and Alzheimer's disease: a progression factor for amyloid-beta-induced cellular perturbation? , 2009, Journal of Alzheimer's disease : JAD.
[29] D. Karger,et al. Bridging high-throughput genetic and transcriptional data reveals cellular responses to alpha-synuclein toxicity , 2009, Nature Genetics.
[30] Thomas C. Wiegers,et al. Comparative Toxicogenomics Database: a knowledgebase and discovery tool for chemical–gene–disease networks , 2008, Nucleic Acids Res..
[31] D. Karger,et al. Bridging the gap between high-throughput genetic and transcriptional data reveals cellular pathways responding to alpha-synuclein toxicity , 2009 .
[32] Charles C. Persinger,et al. How to improve R&D productivity: the pharmaceutical industry's grand challenge , 2010, Nature Reviews Drug Discovery.
[33] Tiago Gil Oliveira,et al. Phospholipase D in brain function and Alzheimer's disease. , 2010, Biochimica et biophysica acta.
[34] A. Barabasi,et al. Network medicine : a network-based approach to human disease , 2010 .
[35] G. MacQueen,et al. The Role of Adipokines in Understanding the Associations between Obesity and Depression , 2010, Journal of obesity.
[36] A. Barabasi,et al. Interactome Networks and Human Disease , 2011, Cell.
[37] R. Sharan,et al. PREDICT: a method for inferring novel drug indications with application to personalized medicine , 2011, Molecular systems biology.
[38] E. Marcotte,et al. Prioritizing candidate disease genes by network-based boosting of genome-wide association data. , 2011, Genome research.
[39] Xing-Ming Zhao,et al. Prediction of Drug Combinations by Integrating Molecular and Pharmacological Data , 2011, PLoS Comput. Biol..
[40] Roded Sharan,et al. PRINCIPLE: a tool for associating genes with diseases via network propagation , 2011, Bioinform..
[41] Tao Jiang,et al. Uncover disease genes by maximizing information flow in the phenome–interactome network , 2011, Bioinform..
[42] Wei Zhang,et al. eResponseNet: a package prioritizing candidate disease genes through cellular pathways , 2011, Bioinform..
[43] E. C. Neto,et al. Association of adipokines and adhesion molecules with indicators of obesity in women undergoing mammography screening , 2012, Nutrition & Metabolism.
[44] Paul M. Thompson,et al. Identification of gene pathways implicated in Alzheimer's disease using longitudinal imaging phenotypes with sparse regression☆ , 2012, NeuroImage.
[45] Adam A. Margolin,et al. The Cancer Cell Line Encyclopedia enables predictive modeling of anticancer drug sensitivity , 2012, Nature.
[46] R. Sharan,et al. INDI: a computational framework for inferring drug interactions and their associated recommendations , 2012, Molecular systems biology.
[47] Shiwen Zhao,et al. A co-module approach for elucidating drug-disease associations and revealing their molecular basis , 2012, Bioinform..
[48] Hua Yu,et al. A Systematic Prediction of Multiple Drug-Target Interactions from Chemical, Genomic, and Pharmacological Data , 2012, PloS one.
[49] R. Altman,et al. Data-Driven Prediction of Drug Effects and Interactions , 2012, Science Translational Medicine.
[50] Guangchuang Yu,et al. clusterProfiler: an R package for comparing biological themes among gene clusters. , 2012, Omics : a journal of integrative biology.
[51] F. Santilli,et al. Platelet activation in obesity and metabolic syndrome , 2012, Obesity reviews : an official journal of the International Association for the Study of Obesity.
[52] Yan Peng,et al. Pharmacogenetics and pharmacogenomics: a bridge to individualized cancer therapy. , 2013, Pharmacogenomics.
[53] Andrew M. Gross,et al. Network-based stratification of tumor mutations , 2013, Nature Methods.
[54] K. Kinzler,et al. Cancer Genome Landscapes , 2013, Science.
[55] P. Sanseau,et al. Computational Drug Repositioning: From Data to Therapeutics , 2013, Clinical pharmacology and therapeutics.
[56] Joshua M. Stuart,et al. The Cancer Genome Atlas Pan-Cancer analysis project , 2013, Nature Genetics.
[57] M. Reale,et al. Cholinergic system dysfunction and neurodegenerative diseases: cause or effect? , 2014, CNS & neurological disorders drug targets.
[58] Helmut Klocker,et al. Oncogenic functions of IGF1R and INSR in prostate cancer include enhanced tumor growth, cell migration and angiogenesis , 2014, Oncotarget.
[59] L Wang,et al. Systematic Analysis of New Drug Indications by Drug-Gene-Disease Coherent Subnetworks. , 2014, CPT: pharmacometrics & systems pharmacology.
[60] C. Evans,et al. Autophagy as a modulator and target in prostate cancer , 2014, Nature Reviews Urology.
[61] David S. Wishart,et al. SMPDB 2.0: Big Improvements to the Small Molecule Pathway Database , 2013, Nucleic Acids Res..
[62] L. Wang,et al. Systematic Analysis of New Drug Indications by Drug-Gene-Disease Coherent Subnetworks , 2014, CPT: pharmacometrics & systems pharmacology.
[63] Yota Otachi,et al. Depth-First Search Using O(n) Bits , 2014, ISAAC.
[64] A. Barabasi,et al. Human symptoms–disease network , 2014, Nature Communications.
[65] Björn Usadel,et al. Trimmomatic: a flexible trimmer for Illumina sequence data , 2014, Bioinform..
[66] Andrei G. Vlassenko,et al. Brain aerobic glycolysis functions and Alzheimer’s disease , 2015, Clinical and Translational Imaging.
[67] A. Barabasi,et al. Uncovering disease-disease relationships through the incomplete interactome , 2015, Science.
[68] Steven L Salzberg,et al. HISAT: a fast spliced aligner with low memory requirements , 2015, Nature Methods.
[69] Benjamin J. Raphael,et al. Pan-Cancer Network Analysis Identifies Combinations of Rare Somatic Mutations across Pathways and Protein Complexes , 2014, Nature Genetics.
[70] Intawat Nookaew,et al. Proteome- and transcriptome-driven reconstruction of the human myocyte metabolic network and its use for identification of markers for diabetes. , 2015, Cell reports.
[71] Núria Queralt-Rosinach,et al. DisGeNET: a discovery platform for the dynamical exploration of human diseases and their genes , 2015, Database J. Biol. Databases Curation.
[72] A. Summerlee,et al. Targeting the relaxin hormonal pathway in prostate cancer , 2015, International journal of cancer.
[73] N. Cordes,et al. Focal adhesion signaling and therapy resistance in cancer. , 2015, Seminars in cancer biology.
[74] T. Tammela,et al. Sotalol, but not digoxin is associated with decreased prostate cancer risk: A population‐based case–control study , 2015, International journal of cancer.
[75] Hai-hua Luo,et al. AB044. AGE/RAGE/Akt pathway contributes to prostate cancer cell proliferation by promoting Rb phosphorylation and degradation , 2015, American journal of cancer research.
[76] Albert-László Barabási,et al. A DIseAse MOdule Detection (DIAMOnD) Algorithm Derived from a Systematic Analysis of Connectivity Patterns of Disease Proteins in the Human Interactome , 2015, PLoS Comput. Biol..
[77] S. Salzberg,et al. StringTie enables improved reconstruction of a transcriptome from RNA-seq reads , 2015, Nature Biotechnology.
[78] Avi Ma'ayan,et al. Regulatory consequences of neuronal ELAV-like protein binding to coding and non-coding RNAs in human brain , 2016, eLife.
[79] Y. Rabinowitz,et al. Genetics in Keratoconus: where are we? , 2016, Eye and Vision.
[80] Emanuel J. V. Gonçalves,et al. A Landscape of Pharmacogenomic Interactions in Cancer , 2016, Cell.
[81] Hu Li,et al. NetDecoder: a network biology platform that decodes context-specific biological networks and gene activities , 2016, Nucleic acids research.
[82] Shi-Hua Zhang,et al. Integrative analysis for identifying joint modular patterns of gene-expression and drug-response data , 2016, Bioinform..
[83] F. Supek,et al. MUFFINN: cancer gene discovery via network analysis of somatic mutation data , 2016, Genome Biology.
[84] Intawat Nookaew,et al. Proteome- and Transcriptome-Driven Reconstruction of the Human Myocyte Metabolic Network and Its Use for Identification of Markers for Diabetes. , 2016, Cell reports.
[85] A. Barabasi,et al. Network-based in silico drug efficacy screening , 2016, Nature Communications.
[86] Susan M. Corley,et al. RNA-Seq analysis and comparison of corneal epithelium in keratoconus and myopia patients , 2018, Scientific Reports.
[87] Lilin Zheng. Plasminogen: a potential target gene for dietary supplements and biomarker of the early stage of obesity by fatigue mice , 2017 .
[88] T. Cassano,et al. Insulin signaling: An opportunistic target to minify the risk of Alzheimer’s disease , 2017, Psychoneuroendocrinology.
[89] Núria Queralt-Rosinach,et al. DisGeNET: a comprehensive platform integrating information on human disease-associated genes and variants , 2016, Nucleic Acids Res..
[90] A. Poggi,et al. The ErbB family and androgen receptor signaling are targets of Celecoxib in prostate cancer. , 2017, Cancer letters.
[91] Yongshuai Jiang,et al. Genome-wide pathway-based association analysis identifies risk pathways associated with Parkinson’s disease , 2017, Neuroscience.
[92] Jian Peng,et al. A Network Integration Approach for Drug-Target Interaction Prediction and Computational Drug Repositioning from Heterogeneous Information , 2017, RECOMB 2017.
[93] Jian Peng,et al. A network integration approach for drug-target interaction prediction and computational drug repositioning from heterogeneous information , 2017, Nature Communications.
[94] Justyna A. Karolak,et al. Collagen synthesis disruption and downregulation of core elements of TGF-β, Hippo, and Wnt pathways in keratoconus corneas , 2017, European Journal of Human Genetics.
[95] Kexin Shen,et al. SUMO-1 Gene Silencing Inhibits Proliferation and Promotes Apoptosis of Human Gastric Cancer SGC-7901 Cells , 2017, Cellular Physiology and Biochemistry.
[96] Benjamin J. Raphael,et al. Network propagation: a universal amplifier of genetic associations , 2017, Nature Reviews Genetics.
[97] Jens Nielsen,et al. Type 2 diabetes and obesity induce similar transcriptional reprogramming in human myocytes , 2017, Genome Medicine.
[98] Albert-László Barabási,et al. Network-based approach to prediction and population-based validation of in silico drug repurposing , 2018, Nature Communications.
[99] M. Passafaro,et al. Glutamatergic synapses in neurodevelopmental disorders , 2017, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[100] Nasser Ghadiri,et al. A review of network‐based approaches to drug repositioning , 2018, Briefings Bioinform..
[101] Lu Lu,et al. DR2DI: a powerful computational tool for predicting novel drug-disease associations , 2018, Journal of Computer-Aided Molecular Design.
[102] Ravi Iyengar,et al. The Library of Integrated Network-Based Cellular Signatures NIH Program: System-Level Cataloging of Human Cells Response to Perturbations. , 2017, Cell systems.
[103] Mariko Sawa,et al. Dysregulation of neurotrophin signaling in the pathogenesis of Alzheimer disease and of Alzheimer disease in Down syndrome. , 2018, Free radical biology & medicine.
[104] F. Huang,et al. δ-Catenin promotes tumorigenesis and metastasis of lung adenocarcinoma. , 2017, Oncology reports.
[105] David S. Wishart,et al. DrugBank 5.0: a major update to the DrugBank database for 2018 , 2017, Nucleic Acids Res..
[106] B. Ogretmen,et al. Sphingolipid metabolism in cancer signalling and therapy , 2017, Nature Reviews Cancer.
[107] Ashton C. Berger,et al. Author Correction: Identification of ADAR1 adenosine deaminase dependency in a subset of cancer cells , 2018, Nature Communications.
[108] M. Gearing,et al. Integrated proteomics and network analysis identifies protein hubs and network alterations in Alzheimer’s disease , 2018, Acta neuropathologica communications.
[109] Fengshan Wang,et al. The Role of Grb2 in Cancer and Peptides as Grb2 Antagonists. , 2017, Protein and peptide letters.
[110] W. Swardfager,et al. The complement cascade in Alzheimer’s disease: a systematic review and meta-analysis , 2019, Molecular Psychiatry.
[111] Ping Xuan,et al. Drug repositioning through integration of prior knowledge and projections of drugs and diseases , 2019, Bioinform..
[112] Salvatore Alaimo,et al. Network-Based Drug Repositioning: Approaches, Resources, and Research Directions. , 2018, Methods in molecular biology.
[113] R. Mailman,et al. Cancer and the Dopamine D2 Receptor: A Pharmacological Perspective , 2019, The Journal of Pharmacology and Experimental Therapeutics.
[114] Albert-László Barabási,et al. Network-based prediction of drug combinations , 2019, Nature Communications.
[115] Isobel S Okoye,et al. E2 ubiquitin-conjugating enzymes in cancer: Implications for immunotherapeutic interventions. , 2019, Clinica chimica acta; international journal of clinical chemistry.
[116] F. Caramia,et al. The Relationships Between Vitamin K and Cognition: A Review of Current Evidence , 2019, Front. Neurol..
[117] A. Carrier,et al. PML hyposumoylation is responsible for the resistance of pancreatic cancer , 2019, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[118] A. Halle,et al. Inhibition of Stat3‐mediated astrogliosis ameliorates pathology in an Alzheimer's disease model , 2019, EMBO molecular medicine.
[119] Joshua M. Korn,et al. Next-generation characterization of the Cancer Cell Line Encyclopedia , 2019, Nature.
[120] Hua Yu,et al. Systematic discovery of novel and valuable plant gene modules by large‐scale RNA‐seq samples , 2018, Bioinform..
[121] Fatemeh Zare-Mirakabad,et al. The assessment of efficient representation of drug features using deep learning for drug repositioning , 2019, BMC Bioinformatics.
[122] F. Sanz,et al. The DisGeNET knowledge platform for disease genomics: 2019 update , 2019, Nucleic Acids Res..
[123] Guiyou Liu,et al. Impact of Vitamin D Binding Protein Levels on Alzheimer's Disease: A Mendelian Randomization Study. , 2020, Journal of Alzheimer's disease : JAD.
[124] Jianzhu Ma,et al. Predicting Drug Response and Synergy Using a Deep Learning Model of Human Cancer Cells. , 2020, Cancer cell.
[125] Hye-Sun Kim,et al. Inhibition of STAT3 phosphorylation attenuates impairments in learning and memory in 5XFAD mice, an animal model of Alzheimer's disease. , 2020, Journal of pharmacological sciences.